Taysha Gene Therapies, Inc. (TSHA)
5.075
+0.02
(+0.30%)
USD |
NASDAQ |
Sep 16, 16:00
5.075
0.00 (0.00%)
After-Hours: 16:31
Taysha Gene Therapies Price : 5.075 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 5.00 | 5.19 | 4.90 | 5.06 | 5.149M |
| Sep 14, 2026 | 5.00 | 5.12 | 4.98 | 5.01 | 6.696M |
| Sep 11, 2026 | 5.26 | 5.28 | 4.98 | 5.02 | 1.778M |
| Sep 10, 2026 | 5.24 | 5.24 | 5.01 | 5.16 | 2.403M |
| Sep 09, 2026 | 5.40 | 5.485 | 5.285 | 5.34 | 1.811M |
| Sep 08, 2026 | 5.57 | 5.575 | 5.40 | 5.48 | 2.223M |
| Sep 04, 2026 | 5.52 | 5.61 | 5.42 | 5.60 | 2.111M |
| Sep 03, 2026 | 5.62 | 5.665 | 5.50 | 5.57 | 1.878M |
| Sep 02, 2026 | 5.73 | 5.96 | 5.55 | 5.64 | 1.989M |
| Sep 01, 2026 | 5.645 | 5.77 | 5.56 | 5.70 | 1.763M |
| Aug 31, 2026 | 5.70 | 5.775 | 5.535 | 5.69 | 2.063M |
| Aug 28, 2026 | 5.89 | 5.915 | 5.625 | 5.77 | 2.071M |
| Aug 27, 2026 | 5.99 | 6.09 | 5.890 | 5.96 | 2.187M |
| Aug 26, 2026 | 6.15 | 6.27 | 5.91 | 6.02 | 1.281M |
| Aug 25, 2026 | 5.99 | 6.27 | 5.99 | 6.20 | 1.691M |
| Aug 24, 2026 | 6.02 | 6.075 | 5.825 | 5.97 | 2.590M |
| Aug 21, 2026 | 6.18 | 6.24 | 6.015 | 6.09 | 2.831M |
| Aug 20, 2026 | 6.04 | 6.30 | 5.92 | 6.11 | 3.397M |
| Aug 19, 2026 | 6.40 | 6.52 | 6.29 | 6.43 | 4.280M |
| Aug 18, 2026 | 6.08 | 6.275 | 6.03 | 6.19 | 1.632M |
| Aug 17, 2026 | 5.93 | 6.27 | 5.82 | 6.21 | 3.051M |
| Aug 14, 2026 | 5.90 | 6.006 | 5.716 | 5.95 | 2.132M |
| Aug 13, 2026 | 6.40 | 6.40 | 5.94 | 5.99 | 2.185M |
| Aug 12, 2026 | 6.13 | 6.449 | 6.01 | 6.405 | 3.914M |
| Aug 11, 2026 | 6.42 | 6.75 | 6.28 | 6.68 | 4.987M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 3.25 |
| Protalix Biotherapeutics, Inc. | 2.685 |
| Humacyte, Inc. | 0.5698 |
| Agenus, Inc. | 7.21 |
| Amgen, Inc. | 376.44 |
Price Related Metrics
| PS Ratio | 317.83 |
| PEG Ratio | -0.5566 |
| Price to Book Value | 4.263 |
| Earnings Yield | -8.52% |
| Market Cap | 1.651B |
| PEGY Ratio | -0.5566 |